Similar Papers

Paper Title
Journal
Date
Author
Biomarkers for immune intervention trials in type 1 diabetes
Roberto Mallone ... Bart O Roep
Clinical Immunology | VOL. 149
Roberto Mallone, et. al.Roberto Mallone ... Bart O Roep
27 Feb 2013
Characterization of Islet-Infiltrating Lymphocytes in Type 1 Diabetes
Jamie L Felton ... Rachel H Bonami
Diabetes | VOL. 67
Jamie L Felton, et. al.Jamie L Felton ... Rachel H Bonami
22 Jun 2018
The Contribution of Neutrophils and NETs to the Development of Type 1 Diabetes.
Alessandra Petrelli ... Riho Fukuda
Frontiers in Immunology | VOL. 13
Alessandra Petrelli, et. al.Alessandra Petrelli ... Riho Fukuda
06 Jul 2022
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Gregory Berry ... Hanspeter Waldner
Journal of Visualized Experiments | VOL. -
Gregory Berry, et. al.Gregory Berry ... Hanspeter Waldner
06 May 2013
View more papers

More From: Pharmacological reviews

Paper Title
Journal
Date
Author
Corrigendum to "Toward a paradigm shift: Oral agents and injectable drugs in the future of obesity management" [Pharmacological Reviews 77 (2025) 100008
Amirhossein Sahebkar ... Ali H Eid
Pharmacological reviews | VOL. 77
Amirhossein Sahebkar, et. al.Amirhossein Sahebkar ... Ali H Eid
07 Mar 2025
Pharmacological strategies to bridge the gap between cancer and cardiovascular therapeutics
Ali H Eid
Pharmacological Reviews | VOL. 77
Ali H EidAli H Eid
01 Mar 2025
Neurobiology of the incubation of drug craving: an update
Jonathan J Chow ... Yavin Shaham
Pharmacological Reviews | VOL. 77
Jonathan J Chow, et. al.Jonathan J Chow ... Yavin Shaham
01 Mar 2025
Drugging dancing protein clouds: A close look at disorder-based drug design
Ali H Eid
Pharmacological Reviews | VOL. 77
Ali H EidAli H Eid
01 Mar 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.